文献速递临床微生物质量管理与危急值

来法莫林对422株金黄色葡萄球菌药敏试验:梯度扩散条与纸片扩散法对比肉汤微量稀释法

Performance of gradient diffusion strip and disk diffusion versus broth microdilution for lefamulin susceptibility testing of 422 Staphylococcus aureus isolates.
PubMed 文献 · J Clin Microbiol · 2026-01-23

该研究以肉汤微量稀释法(BMD)为参考,评估梯度扩散条(GDS)和纸片扩散法(DD)对422株金黄色葡萄球菌(256株MSSA、166株MRSA)来法莫林药敏试验的准确性。GDS分类一致率100%、基本一致率92.2%,无重大误差和极重大误差;DD分类一致率99.5%,但极重大误差率16.7%(1/6)。GDS满足CLSI标准但系统性低估MIC,DD非敏感结果需BMD确认。

要点

  • GDS与BMD分类一致率100%,无重大误差和极重大误差,但MIC系统性偏低0.49 log₂。
  • GDS MIC=0.25 mg/L时建议用BMD确认。
  • DD分类一致率99.5%,但极重大误差率16.7%超过CLSI阈值,非敏感结果需BMD验证。

核心结论

  • 来法莫林GDS满足CLSI标准但系统性低估MIC,BMD确认建议用于GDS MIC=0.25 mg/L。
  • 纸片扩散法一致性极好,但因非敏感菌株稀少导致极重大误差率超过CLSI阈值,任何非敏感结果应经BMD验证。

研究设计与样本

  • 以BMD为参考方法,同时测试GDS和DD,按CLSI M100-S34折点判读:MIC≤0.25 mg/L或抑菌圈直径≥23 mm为敏感。
  • 计算分类一致率、基本一致率、重大误差和极重大误差。

主要发现

  • BMD显示98.6%(416/422)的菌株对来法莫林敏感,6株非敏感(4株MSSA、2株MRSA)。
  • GDS与BMD相比分类一致率100%、基本一致率92.2%,无极重大误差和重大误差,MIC较BMD低0.49 log₂。
  • 20 µg来法莫林纸片扩散法分类一致率99.5%(421/422),极重大误差率16.7%(1/6),重大误差率0.2%(1/416)。

关键数值与推荐

  • CLSI M100-S34折点:MIC≤0.25 mg/L或抑菌圈直径≥23 mm判为敏感。
  • GDS:分类一致率100%,基本一致率92.2%,极重大误差0%,重大误差0%。
  • 纸片扩散法(20 µg):分类一致率99.5%,极重大误差率16.7%(1/6),重大误差率0.2%(1/416)。

临床怎么用

  • GDS可用于常规药敏试验,但当MIC=0.25 mg/L时建议用BMD确认。
  • 纸片扩散法非敏感结果应经BMD验证后方可报告。

局限性

  • 非敏感菌株数量少(仅6株),导致纸片扩散法极重大误差率估计不稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Lefamulin is a novel pleuromutilin antibiotic with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). While broth microdilution (BMD) is the reference method for susceptibility testing, simpler alternatives such as MIC Test Strip (gradient diffusion strip [GDS]) and disk diffusion (DD) are urgently needed for routine laboratories. We evaluated the accuracy of GDS and DD compared to BMD for lefamulin against S. aureus. A total of 422 non-duplicate clinical isolates of S. aureus (256 methicillin-susceptible S. aureus [MSSA] and 166 MRSA) collected between December 2023 and December 2024 at the Affiliated Tai'an Central Hospital of Qingdao University were tested by BMD, GDS, and DD. Interpretation followed CLSI M100-S34 breakpoints (MIC ≤ 0.25 mg/L or zone diameter ≥ 23 mm = susceptible). BMD served as the reference to calculate categorical agreement (CA), essential agreement (EA), major errors (ME), and very major errors (VME). Lefamulin exhibited potent activity against S. aureus, with 98.6% (416/422) of isolates classified as susceptible by BMD; six isolates (four MSSA and two MRSA) were non-susceptible. Compared with BMD, GDS showed 100% CA and 92.2% EA and yielded no VME and ME, and MICs were 0.49 log₂ lower than BMD. Disk diffusion with the 20 µg lefamulin disk achieved 99.5% CA (421/422), with a VME rate of 16.7% (1/6) and an ME rate of 0.2% (1/416). Lefamulin GDS fulfilled CLSI criteria but systematically underestimated MICs; BMD confirmation is advised for GDS MIC = 0.25 mg/L. Disk diffusion showed excellent agreement, yet its VME rate surpassed the CLSI threshold owing to scarce non-susceptible isolates; any non-susceptible result by disk should be verified by BMD. IMPORTANCE: Lefamulin is a new antibiotic active against methicillin-resistant Staphylococcus aureus, but simple susceptibility tests are lacking. We compared two easy-to-perform methods with reference broth microdilution for 422 S. aureus clinical isolates. Both showed high accuracy after on-site confirmation of borderline results and can be immediately implemented in routine laboratories to guide appropriate lefamulin therapy and help contain resistance.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Tian Y, He X, Wu X, et al. Performance of gradient diffusion strip and disk diffusion versus broth microdilution for lefamulin susceptibility testing of 422 Staphylococcus aureus isolates. J Clin Microbiol. 2026. PMID: 41575216. doi:10.1128/jcm.01578-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。